Publications Neuromuscular disorders
Here you can find some of the top publications from our research team
Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Blokhuis AM et al. Acta Neuropathol. 2016 Aug;132(2):175-96.
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. van Rheenen W et al. Nat Genet. 2016 Sep;48(9):1043-8.
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Kenna KP et al. Nat Genet. 2016 Sep;48(9):1037-42.
Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis. Huisman MH et al. JAMA Neurol. 2015 Oct;72(10):1155-62.
C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Koppers M et al. Ann Neurol. 2015 Sep;78(3):426-38.
Cortical thickness in ALS: towards a marker for upper motor neuron involvement. Walhout R et al. J Neurol Neurosurg Psychiatry 2015;86:288-94.
C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome-wide meta-analysis. Diekstra FP et al. Ann Neurol. 2014;76:120-33.
Therapy of amyotrophic lateral sclerosis remains a challenge. Van den Berg LH. Lancet Neurol. 2014;13:1062-3.
Clinical diagnosis and management of amyotrophic lateral sclerosis. Hardiman O, et al. Nat Rev Neurol. 2011 Oct 11;7(11):639-4.
Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Vlam L et al. Nature Rev Neurol. 2011;8:48-58.